MOSCOW (MRC) -- Guangxi Chlor-Alkali Chemical has selected Solvay’s proprietary hydrogen peroxide technology for its new plant in China, said Process-worldwide.
Under the license agreement, Solvay will also provide a dedicated process design package, operating expertise and a range of services for the project.
Solvay has signed a license agreement with Guangxi Chlor-Alkali Chemical (Ghcac) which will enable the Chinese partner to build and operate a hydrogen peroxide mega plant at Qinzhou (Guangxi Zhuang Autonomous Region) designed to support its 300 kilotons propylene oxide (PO) production and other units on site.
Under this license, Solvay will provide its proprietary hydrogen peroxide mega-scale, high productivity process technology to Ghcac, including a dedicated process design package, operating expertise and a range of services to ensure the optimized and reliable production of the new mega plant. In addition, the company will also supply Ghcac with proprietary 2-amylanthraquinone (AQ), the key chemical contributing to the high productivity and environmentally-friendly chemical processes of Solvay’s mega plant technology.
We remind, Solvay announces the completion of the sale of its 50% stake in the RusVinyl joint venture to its joint venture partner Sibur. At the time of closing, Solvay received €433 million in cash proceeds in Belgium which will be reported in the first quarter as cash flow from investing activities (Consolidated statement of cash flows). A capital loss of EUR174 million will be recognized in the first quarter of 2023, mainly reflecting the crystallization of historic currency translation balances.
mrchub.com